60 mg semaglutide SNEAK PEEK: Should teenagers be taking Ozempic? SUNDAY on #60Mins, shifting the weight in a new age of science FDA approves obesity drug that

Some patients achieve their goal weight at 1.0 mg or 1.7 mg and remain there with their providers agreement

The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: A call for research

This medication is typically paused before surgical procedures due to its effect on gastric emptying

The connection between insulin sensitivity and weight loss is profound, and emerging research highlights the unique metabolic benefits of tirzepatide beyond calorie restriction

With convenient once-weekly dosing, it offers a non-surgical option for sustained fat reduction

Regulates blood sugar control by reducing glucose production in the liver and increasing insulin secretion